Biological Therapeutics (S2-PRK-BT)(in Polish: Biological Therapeutics, stacjonarne, drugiego stopnia) | |
second cycle programme full-time, 2-year studies Language: English | Jump to: Opis ogólnyThis degree programme is conducted within the “Integrated Teaching & Learning Development Programme –ZIP 2.0”. It is co-financed by the European Social Fund as part of the European Funds for Social Development Programme 2021–2027 (FERS) (contract no.: FERS.01.05-IP.08-0365/23-00). Thanks to European Funds, Participants of ZIP 2.0 Programme can benefit fromnumerous opportunities including:
Check the rules for participating in the ZIP 2.0 Programme Field: science and natural sciences, medical sciences and health sciences Discipline: biological sciences, chemical sciences, physical sciences, medical sciences Language of instruction: english Professional degree you will be awarded after completing studies : Master's degree Where and when your classes will take place: Place: Classes are held in laboratories on the Ochota Campus: mainly at the Faculty of Physics (Ludwika Pasteura 5) and at the International Institute of Molecular and Cell Biology in Warsaw (Księcia Trojdena 4). Some classes involving guests from outside Warsaw (e.g. representatives of pharmaceutical companies) will be conducted online. Time: Classes are held from Monday to Friday between 8:00 a.m. and 8:00 p.m. What kind of knowledge, skills and competencies you will acquire at this field of studies:
You will learn:
During your studies in Biological Therapeutics, you will gain comprehensive theoretical and practical knowledge in the field of pharmaceutical biotechnology, laboratory and analytical skills, and the competencies necessary to work in the innovative sector of biological and biosimilar drug production, which will allow you to function effectively in the modern pharmaceutical industry. You will acquire the skills to work in research and development and production departments of companies in the biotechnology and biopharmaceutical sectors. Where you can find a job after completing studies On the Biological Therapeutics programme, we place a strong emphasis on developing critical thinking skills and acquiring and processing reliable information creatively. A key part of this is the series of logically connected laboratory exercises we have designed, covering the chemical synthesis of reagents and enzymes necessary for RNA production, the design of antigen-encoding templates for in vitro transcription, and quality control and preclinical testing. You will learn how to package mRNA into lipid nanoparticles using microfluidic techniques, and how to administer these to cells cultured in vitro or to animals. Throughout your studies, you will therefore develop practical expertise in designing, synthesising, purifying and verifying the quality of therapeutic mRNA. You will also become familiar with protein purification methods and learn about monoclonal antibody selection. You will use CRISPR-Cas9 genome editing tools to modify the mouse genome, learning how to genotype in order to select properly modified clones. You will also gain experience in modern sequencing techniques, such as nanopore sequencing, and learn how to analyse data obtained from this type of experiment. The Biological Therapeutics programme is distinguished by its block teaching, which enables complex, multi-stage experiments and makes more effective use of laboratory time. Integrating knowledge from the exact and natural sciences and medicine, the programme prepares specialists for work in modern pharmacy and biotechnology. Are there different specialties and specializations at the field of studies The Biological Therapeutics programme does not offer specialisations. Will you pursue internship during the studies The study programme does not include internships, so they are optional. Is it possible to study one/several semesters at other university Yes, you can participate in the MOST or Erasmus+ programmes. Where you can find more information on the study programme: Visit our website: https://medycyna.uw.edu.pl/wp-content/uploads/sites/138/2025/07/M.2025.249.U.128.pdf |
Qualification awarded:
Access to further studies:
Learning outcomes
The learning outcomes were adopted by Resolution No. 300 of the Senate of the University of Warsaw of 24 June 2026 concerning the study faculty for the Biological Therapeutics degree programme (UW Monitor 2026, item 234), available on the website https://monitor.uw.edu.pl/.
KNOWLEDGE: THE GRADUATE KNOWS AND UNDERSTANDS
K_W01 in-depth molecular mechanisms of action of biological drugs and the chemical basis of their synthesis.
K_W02 in-depth portfolio of contemporary biological drugs and key strategies for their synthesis.
K_W03 in-depth design, manufacture and in vitro and in vivo testing methods for biological drugs.
K_W04 in-depth terminology and key processes and enzymes involved in RNA and protein metabolism.
K_W05 advanced biophysical methods for the study of nucleic acids and proteins.
K_W06 in-depth analysis of the correlations and interdependencies of the cellular processes involved in the expression of genetic information, including co-transcription and co-translation processes.
K_W07 principles for raising research funds, implementing and setting up research projects, protecting intellectual property rights and commercialising research results.
K_W08 principles for creating and developing various forms of entrepreneurship in the country and around the world.
K_W09 in-depth development of biopharmaceuticals and their application in modern medicine.
K_W10 the importance of pre-clinical research in the development of biopharmaceuticals based on proteins or nucleic acids in greater depth.
SKILLS: THE GRADUATE IS ABLE TO
K_U01 design and perform complex experiments, such as in vitro mRNA synthesis, its formulation, and purification of recombinant antibodies.
K_U02 search and analyse literature, databases and use relevant software to design new drugs or preclinical studies.
K_U03 critically analyse the results of multi-stage experiments and re-plan accordingly.
K_U04 take animal tissue samples and isolate RNA or proteins for further molecular analysis.
K_U05 design microfluidic systems for applications in biological research.
K_U06 analyse the RNA-seq data, using selected bioinformatics tools and simplified pipelines.
K_U07 use scientific literature and communicates in English at B2+ level of the Common European Framework of Reference for Languages.
K_U08 take a leading role in the activities of teams, distribute experimental tasks within the team and enforce the responsibilities of team members.
K_U09 use modern research equipment (for example, nanopore sequencers, nanodrop, bioanalyser, dynamic light scattering).
K_U10 train themselves, improve acquired skills and support others in doing this.
K_U11 work with health experts to implement and test new technologies.
SOCIAL COMPETENCES: THE GRADUATE IS READY TO
K_K01 critically analyse the market of biological drugs and the sector of biopharmaceutical companies in Poland and understands the market mechanisms in this sector.
K_K02 Use objective and trusted sources of scientific information.
K_K03 respects and develops professional ethics in science and bioresearch. plan preclinical animal experiments following ethical principles, applicable law and the guidelines of ethics committees.
K_K04 critically present and discuss the results of experiments in English in a forum.
K_K05 fulfilling pro-social commitments, acting in the public interest and thinking and acting in an entrepreneurial manner.
K_K06 implementation of modern medical technologies to protect health and improve quality of life.